DuPont announced that it has completed the divestiture of its Aramids business, which includes well known brands Kevlar and Nomex, to Arclin, a portfolio company of an affiliate of TJC, L.P.. The transaction values the business at approximately $1.8 billion.
As part of the deal, DuPont received approximately $1.2 billion in pre-tax cash proceeds, subject to customary adjustments. The company also received a $300 million note receivable and a non-controlling equity stake in Arclin, currently valued at about $325 million, representing roughly a 16% ownership interest.
DuPont had previously reclassified the Aramids business as discontinued operations beginning in the third quarter of 2025, reflecting its strategic shift away from this segment.
Arclin, headquartered in Alpharetta, Georgia, focuses on materials science and polymer technologies, serving industries including construction, agriculture, transportation infrastructure, electronics, and pharmaceuticals. The acquisition expands Arclin’s capabilities in high-performance fibers used in protective and industrial applications.
TJC, the private equity firm backing Arclin, manages over $30 billion in assets and has a long track record of investing across industrial, healthcare, and technology sectors.
The completion of the transaction marks another step in DuPont’s ongoing portfolio transformation as it sharpens its focus on core growth areas such as healthcare, water, construction, and industrial solutions.
